{
  "emaEpar": [
    {
      "activeSubstance": "trabectedin",
      "conditionIndication": "Yondelis is indicated for the treatment of patients with advanced soft-tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. Efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.Yondelis in combination with pegylated liposomal doxorubicin (PLD) is indicated for the treatment of patients with relapsed platinum-sensitive ovarian cancer.",
      "inn": "trabectedin",
      "marketingAuthorisationDate": "2007-09-17 00:00:00",
      "marketingAuthorisationHolder": "Pharma Mar S.A.",
      "medicineName": "Yondelis",
      "url": "https://www.ema.europa.eu/en/medicines/human/EPAR/yondelis"
    }
  ],
  "fdaDrugLabel": [
    {
      "brand": "YONDELIS",
      "indication": "1 INDICATIONS AND USAGE YONDELIS \u00ae is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen [see Clinical Studies (14) ] . YONDELIS is an alkylating drug indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen ( 1 )",
      "manufacturer": "Janssen Products, LP",
      "splSetId": "472bd78e-be17-4b9d-90f4-9482c3aec9ff"
    }
  ],
  "id": "Trabectedin",
  "nciThesaurus": {
    "casRegistry": "114899-77-3",
    "chebiId": "",
    "chemicalFormula": "C39H43N3O11S",
    "definition": "A tetrahydroisoquinoline alkaloid isolated from the marine tunicate Ecteinascidia turbinata with potential antineoplastic activity. Binding to the minor groove of DNA, trabectedin interferes with the transcription-coupled nucleotide excision repair machinery to induce lethal DNA strand breaks and blocks the cell cycle in the G2 phase.",
    "fdaUniiCode": "ID0YZQ2TCP",
    "identifier": "C1691",
    "preferredName": "Trabectedin",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C2115"
    ],
    "synonyms": [
      "ET-743",
      "Ecteinascidin",
      "Ecteinascidin 743",
      "Spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1'(2'H)-isoquinolin)-19-one, 3',4',6,6a,7,13,14,16-Octahydro-5-(acetyloxy)-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-, (6R-(6-alpha,6a-beta,7-beta,13-beta,14-beta,16-alpha,20R*))-",
      "TRABECTEDIN",
      "Trabectedin",
      "Yondelis",
      "ecteinascidin 743",
      "trabectedin"
    ]
  }
}